HLYK — HealthLynked Cashflow Statement
0.000.00%
- $6.03m
- $13.46m
- $2.07m
Annual cashflow statement for HealthLynked, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.4 | -8.07 | -1.01 | -6.13 | -3.28 |
| Depreciation | |||||
| Non-Cash Items | 6.09 | 1.87 | -2.72 | 2.21 | 1.11 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.278 | 1 | -0.76 | 0.144 | 0.355 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -3.77 | -4.36 | -4.14 | -3.49 | -1.71 |
| Capital Expenditures | -0.019 | -0.024 | -0.002 | -0.003 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.322 | -0.521 | 3.51 | 0.425 | 0.125 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.341 | -0.545 | 3.51 | 0.422 | 0.125 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.24 | 1.68 | 0.824 | 2.9 | 1.55 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.13 | -3.23 | 0.185 | -0.171 | -0.039 |